RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Teva Pharmaceutical Industries Stock

Teva Pharmaceutical Industries ROA 2025

Teva Pharmaceutical Industries ROA

-0.01

Ticker

TEVA.TA

ISIN

IL0006290147

WKN

906517

In 2025, Teva Pharmaceutical Industries's return on assets (ROA) was -0.01, a -76.87% increase from the -0.06 ROA in the previous year.

Teva Pharmaceutical Industries Aktienanalyse

What does Teva Pharmaceutical Industries do?

Teva Pharmaceutical Industries Ltd is a leading global company in the pharmaceutical industry. The company was founded in 1901 in Jerusalem, Israel, as Salomon, Levin and Company. The name Teva was adopted later in 1976. Teva's business model focuses on manufacturing and distributing high-quality and affordable pharmaceuticals worldwide. The company specializes in generics, as well as specialty pharmaceuticals. Teva has made a name for itself through its strong brand presence, focus on developing affordable medications, and production of biosimilars. Teva is divided into various divisions that focus on the manufacturing and distribution of pharmaceuticals. One of these divisions is the generics division, in which the company targets both the domestic and international markets. Teva's research and development division is known for developing biotechnology-based medications. The specialty pharmaceuticals division focuses on rare and difficult-to-treat diseases, such as multiple sclerosis and Parkinson's disease, and develops new treatment options. Teva is also commercially active in the field of biosimilars, which offer medications based on biological sources. These medications offer higher efficacy and fewer side effects than conventional medications. Teva has taken a leading role in this division by offering medications with high standards, serving a significant growth market. The company offers a variety of products, including prescription medications, over-the-counter products, and veterinary medicine. Some of Teva's popular products include Azilect (a medication for Parkinson's treatment), Copaxone (a medication for multiple sclerosis treatment), QVAR (a medication for asthma treatment), Azor (a medication for hypertension treatment), and ProAir (a medication for asthma treatment). Teva has a long-standing history in the pharmaceutical industry and has established an impressive global presence. The company has strong structures not only in Israel but also in other countries such as the United States, Europe, and Asia. It has maintained an impressive growth strategy and has become a major player in global healthcare. Overall, Teva has established itself as a key company in the pharmaceutical industry. It has a strong focus on affordability and quality of medications, with particular emphasis on the development of biosimilars and biotechnology. The company has a wide range of products and divisions that cater to the needs of customers worldwide. Teva Pharmaceutical Industries ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Teva Pharmaceutical Industries's Return on Assets (ROA)

Teva Pharmaceutical Industries's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Teva Pharmaceutical Industries's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Teva Pharmaceutical Industries's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Teva Pharmaceutical Industries’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Teva Pharmaceutical Industries stock

What is the Return on Assets (ROA) of Teva Pharmaceutical Industries this year?

The Return on Assets (ROA) of Teva Pharmaceutical Industries is -0.01 undefined this year.

What was the ROA of Teva Pharmaceutical Industries compared to the previous year?

The ROA of Teva Pharmaceutical Industries has increased by -76.87% compared to the previous year.

What consequences do high ROA have for investors of Teva Pharmaceutical Industries?

A high ROA is advantageous for investors of Teva Pharmaceutical Industries, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Teva Pharmaceutical Industries?

A low ROA can be unfavorable for investors of Teva Pharmaceutical Industries as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Teva Pharmaceutical Industries affect the company?

An increase in ROA of Teva Pharmaceutical Industries can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Teva Pharmaceutical Industries impact the company?

A reduction in the ROA of Teva Pharmaceutical Industries can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Teva Pharmaceutical Industries?

Some factors that can influence the ROA of Teva Pharmaceutical Industries include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Teva Pharmaceutical Industries important for investors?

The ROA of Teva Pharmaceutical Industries is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Teva Pharmaceutical Industries take to improve ROA?

To improve ROA, Teva Pharmaceutical Industries can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Teva Pharmaceutical Industries pay?

Over the past 12 months, Teva Pharmaceutical Industries paid a dividend of 3.1 USD . This corresponds to a dividend yield of about 0.14 %. For the coming 12 months, Teva Pharmaceutical Industries is expected to pay a dividend of 117.98 USD.

What is the dividend yield of Teva Pharmaceutical Industries?

The current dividend yield of Teva Pharmaceutical Industries is 0.14 %.

When does Teva Pharmaceutical Industries pay dividends?

Teva Pharmaceutical Industries pays a quarterly dividend. This is distributed in the months of April, July, September, December.

How secure is the dividend of Teva Pharmaceutical Industries?

Teva Pharmaceutical Industries paid dividends every year for the past 3 years.

What is the dividend of Teva Pharmaceutical Industries?

For the upcoming 12 months, dividends amounting to 117.98 USD are expected. This corresponds to a dividend yield of 5.44 %.

In which sector is Teva Pharmaceutical Industries located?

Teva Pharmaceutical Industries is assigned to the 'Health' sector.

Wann musste ich die Aktien von Teva Pharmaceutical Industries kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Teva Pharmaceutical Industries from 12/12/2017 amounting to 0.298 USD, you needed to have the stock in your portfolio before the ex-date on 11/28/2017.

When did Teva Pharmaceutical Industries pay the last dividend?

The last dividend was paid out on 12/12/2017.

What was the dividend of Teva Pharmaceutical Industries in the year 2024?

In the year 2024, Teva Pharmaceutical Industries distributed 0 USD as dividends.

In which currency does Teva Pharmaceutical Industries pay out the dividend?

The dividends of Teva Pharmaceutical Industries are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Teva Pharmaceutical Industries

Our stock analysis for Teva Pharmaceutical Industries Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Teva Pharmaceutical Industries Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.